Intent to Sole Source Specific Pathogen Free Fertile Eggs
Archived on December 19, 2025. Original response deadline: . Full description on SAM.gov.
Overview
- Response deadline
- 5:00 PM EST
- Posted
- November 19, 2025
- Notice type
- Special Notice
- NAICS
- 112310: Chicken Egg Production
- Agency
- Department of Health and Human Services
Notice details
- Place of performance
- Atlanta, Georgia, 30345
- PSC
- AJ13: GENERAL SCIENCE & TECHNOLOGY R&D SVCS; GENERAL SCIENCE & TECHNOLOGY; EXPERIMENTAL DEVELOPMENT
- Last updated
- Nov 6, 2026
- First published
- Last updated on SAM.gov
Identifiers
- Solicitation number
- 75D301-26-Q-78762
- Notice ID
- 144980f79c114fe59d95418fa314b2ea
Description
The Center for Disease Control and Prevention (CDC), National Center for Immunization and Respiratory Diseases Influenza Division (NCIRD/ID), intends to award a sole source purchase order in accordance with FAR 13.106-1(b)(1), soliciting from a single source, to Avian Vaccine Services LLC, Address:1 Wisconsin Avenue, Suite 100, Norwich, CT 06360, for Specific Pathogen Free (SPF) Fertile Chicken Eggs. The purpose of this requirement is to furnish Research-Specific Pathogen-Free Eggs for the production of high-growth reassortant influenza candidate vaccine viruses and live attenuated influenza virus vaccine (LAIV) candidates, and generation of intial egg isolates from original clinical material.The NAICS code for this procurement is 112310, Chicken Egg Production.
The vaccine seed candidates must have the antigenic properties of the recommended strain and improved growth properties for more efficient vaccine production. SPF Eggs are produced under strictly isolated conditions to guarantee the absence of all disease agents and antibodies against specified agents, which are laid down in the European Pharmacopoecia and by the USDA. SPF Eggs from Avian Vaccine Services have resulted in the successful production of candidate vaccine viruses in the past and have optimized laboratory protocols. Genetics vary between the chicken flocks that supply SPF eggs. Additionally, variations of the microbiome among supplier flocks are expected. Obtaining genetically distinct SPF eggs from alternate suppliers may lead to changes in the isolation rate and potential quality of resulting isolates. This could risk the ability of the Influenza Division to provide candidate vaccine egg viruses to manufacturers in a timely manner.
As a result of this notice, no competitive solicitation will be posted on SAM.gov. The government will issue only one solicitation to Avian Vaccine Services. However, firms that believe they can meet this requirement are encouraged to identify themselves and give written notice by providing a capability statement to the contract specialist, Dawnnia Daley, at xwf5@cdc.gov by December 4, 2025, at 5:00 p.m. ET. The contract specialist will not respond to verbal requests. All requests must be in writing.
A determination by the government not to take this proposed action will be based on responses to this notice and is solely within the discretion of the contracting officer. Information received will be considered solely for the purpose of determining whether to conduct a competitive procurement. Inquiries shall reference the solicitation number, 75D301-26-Q-78762, on the subject line and be sent to Dawnnia Daley by email at xwf5@cdc.gov.
Award Overview
No prior contract identified
No prior award matched this notice's agency, NAICS, place of performance and PSC within 18 months. It may be a new requirement.
Contacts
Contracting Officer
Primary Contact
Secondary Contact
Documents
No documents available.
Lifecycle
- 3Version 3Special NoticeArchivedCurrent
Intent to Sole Source Specific Pathogen Free Fertile Eggs
Similar Opportunities
Title | Match | Phase | Deadline |
|---|---|---|---|
This BAA furthers NIOSH's statutory authority responsibilities for occupational mine safety and health research, including authority established under MINER Act of 2006 and in response to congressional direction supporting research on 1. Deep mining of critical minerals and metals, and 2. Air polluntant exposure risk in FY26. | - | Solicitation | 01/11/2027 |
The NIOSH OMSHR is seeking proposals from universities or colleges with ABET-accredited programs in mining engineering specifically focused on aspects of mining safety and health that addresses research, exploratory development, or testing of new innovations and technologies, and/or methods of evaluation of new and existing mining practices to improve mine health and/or safety. | - | Solicitation | 01/11/2027 |
The goal of this solicitation is to accelerate the development, adaptation, evaluation, demonstration, and adoption of innovative technologies that improve the safety and health of mine workers across coal, metal, nonmetal, stone, sand, and gravel mining operations. NIOSH seeks applied research and technology-development efforts that have a credible pathway toward practical implementation in surface or underground mines. Of particular interest are projects that: 1) Advance promising prototype technologies toward mine-ready solutions, including final development, adaptation to challenging mining environments, modification to meet applicable permissibility requirements, and demonstration at mine sites. 2) Adapt technologies successfully used in other industries for mining applications, including necessary redesign, ruggedization, integration, permissibility modifications, performance evaluation, and in-mine demonstration. 3) Evaluate emerging or candidate technologies to determine their potential to improve mine worker safety and health, identify technical or operational barriers to implementation, and develop approaches for overcoming those barriers. 4) Facilitate adoption of mature safety and health technologies that are available but have not achieved widespread mining-industry implementation. Activities may include establishing initial operational capability through mine demonstrations, evaluating technology performance and usability, identifying barriers to adoption, and determining modifications needed for practical industry acceptance. 5) Conduct analyses that identify emerging hazards and future technology needs, including analysis of safety, health, injury, fatality, exposure, surveillance, operational, or other relevant data to inform future research and technology-development priorities. | - | Solicitation | 02/08/2027 |
Centers for Disease Control (CDC) is issuing this synopsis as a means of conducting market research to identify parties having an interest in and the resources to support this requirement for a California-based integrated health care system to serve as an electronic health record site in CDC’s VISION 2.0 respiratory pathogen surveillance network, providing integrated, longitudinal medical, laboratory, pharmacy, vaccination, claims, and outcomes data to support influenza surveillance, vaccine-effectiveness studies, and related respiratory pathogen research across emergency/urgent care, inpatient, and intensive care unit (ICU) settings. The result of this market research will contribute to determining the method of acquisition. The applicable North American Industry Classification System (NAICS) code assigned to this acquisition is 541380- Testing Laboratories and Services. | - | Market Research | 12/04/2026 |
NOTICE OF INTENT TO AWARD A SOLE-SOURCE MODIFICATION Security Guard Services — CDC Facilities, Metro Atlanta, Georgia and Fort Collins, Colorado Contract No. 75D30125C20468 NAICS Code: 561612, Security Guards and Patrol Services (size standard: $29 Million Dollars) Place of Performance: CDC-owned and leased facilities, metro Atlanta, Georgia and Fort Collins, Colorado Period of the Proposed Action: January 1, 2027 through January 31, 2027 Response Date: 1:00 PM Eastern Time, November 19, 2026 Intent and Authority The Centers for Disease Control and Prevention (CDC) intends to negotiate a sole-source modification to Contract No. 75D30125C20468 with Chenega Global Protection, LLC for one month of continued security guard services covering January 1 through January 31, 2027. The proposed action is authorized under FAR 6.103-1, Only one responsible source and no other supplies or services will satisfy agency requirements (41 U.S.C. 3304(a)(1)). Purpose The modification will maintain continuous, uninterrupted security guard coverage at CDC facilities in metro Atlanta, Georgia and Fort Collins, Colorado during the January 2027 transition-in period of the competitively awarded follow-on contract. The ongoing requirement for these services has been competed; this action is confined to the single transition month. Basis for the Sole-Source Determination Chenega Global Protection, LLC is the only responsible source able to perform this requirement without interruption during the January 1–31, 2027 window. The requirement is not merely to perform security guard services for one month. It is to assume full coverage of the security of multiple CDC campuses, including a BSL-4 select-agent laboratory and Sensitive Compartmented Information Facility (SCIF) posts on January 1, 2027 with no lapse, and to relinquish those posts to the follow-on contractor on February 1, 2027. Guard personnel at these posts must already hold the requisite security clearances, CDC facility credentials and access badges, site- and post-specific certifications, and current weapons qualifications. The incumbent’s workforce is already fully cleared, credentialed, badged, post-certified, and in place. Any source other than the incumbent would first have to complete its own transition-in — clearances, credentialing, badging, post certification, and weapons qualification — before January 1, 2027, and then immediately execute a transition-out thirty days later. The Government has determined, and has structured the follow-on contract to reflect, that a new contractor requires the full period of January 1–31, 2027 to complete transition-in alone. Any lapse, gap, or partial coverage would create an unacceptable risk to life safety, to the physical security of select agents at the BSL-4 laboratory, and to classified national-security information within the SCIF. Accordingly, for this limited period, only one responsible source can satisfy the agency’s requirement. Capability Statements All responsible sources may submit a capability statement, which the agency will consider. To be responsive, a capability statement should address how the respondent would complete transition-in at the identified CDC facilities — including security clearances, credentialing, badging, post certification, and weapons qualification — so as to assume full post coverage effective January 1, 2027, and complete transition-out to the follow-on contractor by January 31, 2027, with no lapse or degradation in coverage at any point during the period. Notice Limitations This notice is not a request for competitive quotations and is not a solicitation. A determination by the Government not to compete this proposed action based on responses to this notice is solely within the discretion of the Government. Information received will be considered solely for the purpose of determining whether to conduct a competitive procurement. The Government will not reimburse any costs associated with responding to this notice. Submission Instructions Capability statements must be received by Contracting Officer Mike Davis at VWL8@CDC.GOV no later than 1:00 PM Eastern Time on November 19, 2026. Responses received after that time will not be considered. | - | Pre-Solicitation | 11/19/2026 |
Additional Details
Solicitation Number
75D301-26-Q-78762
Archive Date
Dec 19, 2025
Office Address
Washington, DC, 20201, US